← Leaderboards
Venkata Mangalampalli
Leidos Biomedical Research, Inc.
$11,808,611
Attributed
$11,808,611
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $9.3M · FY2022–25$10M$7.5M$5M$2.5M$0
'22
'23
'24
'25
Funding mix
By agency
NIH$11,808,611 · 1
By mechanism
N01$11,808,611 · 1
Top collaborators
No co-investigators on record.
Most similar at Leidos Biomedical Research, Inc.
Same institution · by research overlap
- David Heimbrook$2,362,140,846
- Leonard Freedman$1,216,107,431
- Lynn Briscoe$495,968,635
- Ethan Dmitrovsky$597,515,186
- George Mitra$28,582,538
Others in their field
Other Rising Stars on “Shipping”
- Eric M Benway · Woods Hole Oceanographic Institution$32,293,242
- Dennis Eyler · Fisher Bioservices, Inc.$17,091,540
- Joost Van Der Zwaag · University Of California-San Diego Scripps Inst Of Oceanography$15,846,434
- Richard Schrock · Fisher Bioservices, Inc.$13,310,452
- Gregory Higgins · University Of Washington$12,465,760
- Frank A Provenzano · St. Joseph'S Hospital And Medical Center$8,533,907
Research focus
ShippingAnalytical MethodBioreactorsCell BankChemistryClinical ResearchCyclic GmpEquipment And Supply InventoriesGenerationsGenesGene TherapyInterestInvestigational New Drug ApplicationSerotypingAdeno-Associated Viral VectorManufacturing ProcessNational Center For Advancing Translational SciencesOpen SourcePharmaceutical PreparationsPreparationManufactureRare Diseases
Grant awards (3)
NCATS-DPI-22-0101 - CREATION OF AN OPEN-SOURCE PROCESS TO MANUFACTURE AAV VECTOR-BASED GENE THERAPY CANDIDATES FOR NON-COMMERCIAL CLINICAL STUDIES$52,056
N01 · FY2025 · TR · contact PI
NCATS-DPI-22-0101 - CREATION OF AN OPEN-SOURCE PROCESS TO MANUFACTURE AAV VECTOR-BASED GENE THERAPY CANDIDATES FOR NON-COMMERCIAL CLINICAL STUDIES$2,448,234
N01 · FY2024 · CA · contact PI
NCATS-DPI-22-0101 - CREATION OF AN OPEN-SOURCE PROCESS TO MANUFACTURE AAV VECTOR-BASED GENE THERAPY CANDIDATES FOR NON-COMMERCIAL CLINICAL STUDIES$9,308,321
N01 · FY2022 · CA · contact PI